Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

類似資料

• Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
  著者:: Lemaire, Maryse, 等
  出版事項: (2008)
• Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
  著者:: Momparler, Richard L.
  出版事項: (2013)
• A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
  著者:: Momparler, Richard L.
  出版事項: (2012)
• Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
  著者:: Momparler, Richard L, 等
  出版事項: (2014)
• Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells
  著者:: Momparler, Richard L., 等
  出版事項: (2017)